Allogene | 1.69 +0.06 +3.68% | ||
| ALLO | |||
| 高 1.75 | 开 1.66 | 量 396.08万股 | 总市值 3.80亿 |
| 低 1.63 | 换 1.76% | 额 672.17万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
@Kertosis : 梅奥诊所关于Carvykti延迟神经毒性的分析 $传奇生物(LEGN)$
治疗时间范围：2022年2月1日至2024年12月31日
论文的英文标题：Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma
论文链接：...
治疗时间范围：2022年2月1日至2024年12月31日
论文的英文标题：Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma
论文链接：...
4讨论
Allogene(ALLO)
01-24 05:25
$Allogene(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001851044-26-000003 Size: 4 KB 网页链接
Allogene(ALLO)
02-05 06:15
$Allogene(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001362155-26-000002 Size: 10 KB 网页链接
Allogene(ALLO)
2025-11-14 08:15
$Allogene(ALLO)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001296549-25-000005 Act: 34 Size: 15 KB 网页链接
Allogene(ALLO)
2025-11-20 05:15
$Allogene(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-25-000094 Size: 5 KB 网页链接
Allogene(ALLO)
02-03 05:55
$Allogene(ALLO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000843 Act: 33 Size: 4 KB 网页链接
Allogene(ALLO)
02-03 06:25
$Allogene(ALLO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000850 Act: 33 Size: 4 KB 网页链接
Allogene(ALLO)
02-05 06:25
$Allogene(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-26-000009 Size: 12 KB 网页链接
Allogene(ALLO)
02-05 06:15
$Allogene(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-26-000002 Size: 10 KB 网页链接
Allogene(ALLO)
02-03 05:55
$Allogene(ALLO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000842 Act: 33 Size: 5 KB 网页链接
Allogene(ALLO)
2025-11-18 08:15
$Allogene(ALLO)$ 144 Report of proposed sale of securities Accession Number: 0002057918-25-000002 Act: 33 Size: 4 KB 网页链接
Allogene(ALLO)
02-03 06:25
$Allogene(ALLO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000848 Act: 33 Size: 4 KB 网页链接
Allogene(ALLO)
02-05 06:05
$Allogene(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001296549-26-000002 Size: 12 KB 网页链接
Allogene(ALLO)
02-05 06:15
$Allogene(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-26-000005 Size: 10 KB 网页链接
Allogene(ALLO)
2025-11-13 05:45
$Allogene(ALLO)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001611024-25-000004 Act: 34 Size: 26 KB 网页链接
Allogene(ALLO)
2025-11-14 08:15
$Allogene(ALLO)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001422849-25-000094 Act: 34 Size: 7 KB 网页链接
Allogene(ALLO)
2025-12-23 08:05
$Allogene(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001221355-25-000005 Size: 7 KB 网页链接
Allogene(ALLO)
01-22 08:55
$Allogene(ALLO)$ 144 Report of proposed sale of securities Accession Number: 0001851044-26-000001 Act: 33 Size: 4 KB 网页链接
Allogene(ALLO)
02-03 06:25
$Allogene(ALLO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000851 Act: 33 Size: 4 KB 网页链接
Allogene(ALLO)
02-03 06:25
$Allogene(ALLO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000849 Act: 33 Size: 5 KB 网页链接